期刊文献+

卵巢早衰98例临床特征分析 被引量:34

Clinical features of 98 women with premature ovarian failure.
原文传递
导出
摘要 目的了解卵巢早衰(prematureovarianfailure,POF)患者的临床特征及治疗现状,以指导临床对POF的诊治。方法回顾性分析2001-08-2004-03北京大学第三医院98例POF患者的临床特征,对98例POF患者和25例正常对照患者的临床数据进行比较,并对POF组中有无家族史者进行临床特征比较。结果21例POF患者有家族史,占21·4%。83例(84·7%)患者阴道超声可探及至少一侧卵巢,20例(20·4%)患者有卵泡样回声,8例有排卵。POF组初潮年龄与对照组无差别,POF组BMI大于对照组(P<0·05)。POF组子宫体积和卵巢体积较对照组明显减小(P<0·01)。POF组抗核抗体阳性率高,但无统计学意义(P>0·05)。家族性POF和散发性POF的临床特征无明显差别。28·6%的患者缺乏规范化的激素替代治疗(hormonereplacementtreatment,HRT)。结论遗传因素和自身免疫因素在POF的发病中占一定地位,但大部分POF为特发性不明原因。POF患者应进行长期的HRT治疗,预防并发症,而赠卵胚胎移植是POF患者获得妊娠的最有效的治疗。 Objective To explore clinical features and current treatment status in Chinese women with premature ovarian failure (POF). Methods A retrospective study for clinical features was conducted on 98 women with premature ovarian failure from August 2001 to March 2004 in Peking University Third Hospital. Compare the clinical parameters between 98 POF patients and 25 controls with normal ovarian function. Compare the clinical features between the familial and sporadic POF. Results Twenty-one(21.4% ) eases had family history of POF or early menopause (EM). At least one ovary was visualized in 84. 7% of the POF patients by vaginal ultrasound. The detection of follicular activity was found in 20 (20.4%) patients and ovulation was found in 8 eases. There were no differences in menarehe age in POF patients and controls. The BMI in POF patients was greater than that in controls ( P 〈 0. 05 ). Mean uterine and ovarian volume was significantly smaller in POF group as compared with the control group (P 〈0. 01 ). Anti-nuclear antibodies (ANA) were found more frequently in patients with POF than in control patients, but there were no significant differences ( P 〉 0. 05 ). There were no significant differences in clinical features between familial POF and sporadic POF except more eases of regular menses before menopause in familial POF (90. 5% vs 81.8% ). 28. 6% POF patients lacked standardized hormone replacement treatment (HRT). Conclusion Genetic and autoimmune disorders are the main causes of POF, but its eti- ologies remain unknown in most eases. Long-term HRT is needed to prevent long-term health sequel of estrogen deficiency. The only proven therapy for abtalning a pregnancy in POF patients is fertilization of a donor ooeyte.
出处 《中国实用妇科与产科杂志》 CAS CSCD 北大核心 2007年第1期47-49,共3页 Chinese Journal of Practical Gynecology and Obstetrics
关键词 卵巢早衰 抗核抗体 激素替代治疗 Premature ovarian failure Anti-nuclear antibodies Hormone replacement treatment
  • 相关文献

参考文献10

  • 1Coulam CB,Adamson SC,Annegers JF.Incidence of premature ovarian failure[J].Obstet Gynecol,1986,67(4):604-606. 被引量:1
  • 2徐苓,赵珩,葛秦生.围绝经期的流行病学调查[J].生殖医学杂志,1993,2(1):23-27. 被引量:105
  • 3Anasti JN.Premature ovarian failure:an update[J].Fertil Steril,1998,70(1):1-15. 被引量:1
  • 4Coulam CB,Stringfellow S,Hoefnagel D.Evidence for a genetic factor in the etiology of premature ovarian failure[J].Fertil Steril,1983,40(5):693-695. 被引量:1
  • 5Vegetti W,Grazia TM,Testa G,et al.Inheritance in idiopathic premature ovarian failure:analysis of 71 cases[J].Hum Reprod,1998,13(7):1796-1800. 被引量:1
  • 6Van Kasteren YM,Hundscheid RD,Smits AP,et al.Familial idiopathic premature ovarian failure:an overrated and underestimated genetic disease?[J].Hum Reprod,1999,14(10):2455-2459. 被引量:1
  • 7Kim TJ,Anasti JN,Flack MR,et al.Routine endocrine screening for patients with karyotypically normal spontaneous premature ovarian failure[J].Obstet Gynecol,1997,89(5):777-779. 被引量:1
  • 8Ishizuka B,Kudo Y,Amemiya A,et al.Anti-nuclear antibodies in patients with premature ovarian failure[J].Hum Reprod,1999,14 (1):70-75. 被引量:1
  • 9Goswami D,Conway G.Premature ovarian failure[J].Hum Reprod Update,2005,11(4):391-410. 被引量:1
  • 10van Kasteren YM,Schoemaker J.Premature ovarian failure:a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy[J].Hum Reprod,1999,14(5):483-492. 被引量:1

共引文献104

同被引文献259

引证文献34

二级引证文献247

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部